Mark Chin
Director/Board Member en DISC MEDICINE, INC. .
Fortuna: 28 191 $ al 31/03/2024
Perfil
Mark Chin is currently a Director at Optikira LLC, Depixus SAS, Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., Disc Medicine Opco, Inc., Ensoma, Inc., Disc Medicine, Inc., and Avoro Ventures LLC.
He previously held positions as a Director at Aura Biosciences, Inc., Independent Director at Iterum Therapeutics Plc, Independent Director at Imara, Inc., Managing Director at Arix Bioscience Plc, Investment Director at Arix Bioscience Plc, Director at VelosBio, Inc., Director at Pyxis Oncology, Inc., Director at Gemini Therapeutics, Inc., Managing Director at Arix Bioscience, Independent Director at Harpoon Therapeutics, Inc., and Principal at Gilead Sciences, Inc. He also worked as a Consultant at The Boston Consulting Group, Inc., Manager at Professional Services, and Manager at Genentech Ventures, Inc. Mr. Chin received a graduate degree from the University of Pennsylvania, an undergraduate degree from the University of California San Diego, and an MBA from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ITERUM THERAPEUTICS PLC
0.14% | 30/11/2023 | 18 306 ( 0.14% ) | 28 191 $ | 31/03/2024 |
DISC MEDICINE, INC.
-.--% | 09/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Mark Chin
Empresas | Cargo | Inicio |
---|---|---|
DISC MEDICINE, INC. | Director/Board Member | 01/09/2021 |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Director/Board Member | - |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Director/Board Member | 01/09/2021 |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Director/Board Member | - |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Director/Board Member | - |
Optikira LLC
Optikira LLC BiotechnologyHealth Technology Optikira LLC engages in the development of novel therapeutics to prevent cell death diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis. The company was founded by Bradley Backes, Dustin Maly, Scott Oakes, and Feroz Papa in 2015 and is headquartered in Cleveland, OH. | Director/Board Member | - |
Avoro Ventures LLC
Avoro Ventures LLC Investment ManagersFinance Avoro Ventures LLC (Avoro Ventures) is a venture capital subsidiary of Avoro Capital Advisor LLC founded in 2020. The firm is headquartered in New York. | Private Equity Investor | 01/12/2023 |
Antiguos cargos conocidos de Mark Chin.
Empresas | Cargo | Fin |
---|---|---|
HARPOON THERAPEUTICS, INC. | Director/Board Member | 11/03/2024 |
░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formación de Mark Chin.
University of Pennsylvania | Graduate Degree |
University of California San Diego | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 6 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
AURA BIOSCIENCES, INC. | Health Technology |
ITERUM THERAPEUTICS PLC | Health Technology |
HARPOON THERAPEUTICS, INC. | Health Technology |
ARIX BIOSCIENCE PLC | Finance |
PYXIS ONCOLOGY, INC. | Health Technology |
Empresas privadas | 16 |
---|---|
Optikira LLC
Optikira LLC BiotechnologyHealth Technology Optikira LLC engages in the development of novel therapeutics to prevent cell death diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis. The company was founded by Bradley Backes, Dustin Maly, Scott Oakes, and Feroz Papa in 2015 and is headquartered in Cleveland, OH. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Professional Services
Professional Services Information Technology ServicesTechnology Services Part of NIKE, Inc., Professional Services is an American marine services company that offers top-notch maritime solutions ensuring excellence in every project. The private company also provides marine services in UAE for seamless and reliable options. Professional Services LLC takes pride in the delivery of the most reliable and high-quality underground services work in Emirates. Professional Services was acquired by Exds, Inc. from Network-1 Technologies, Inc on February 10, 2000 for $4 million. | Technology Services |
Genentech Ventures, Inc.
Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Finance |
Imara, Inc.
Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Commercial Services |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | Commercial Services |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Finance |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Commercial Services |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Avoro Ventures LLC
Avoro Ventures LLC Investment ManagersFinance Avoro Ventures LLC (Avoro Ventures) is a venture capital subsidiary of Avoro Capital Advisor LLC founded in 2020. The firm is headquartered in New York. | Finance |
Disc Medicine, Inc. | |
Longitude Capital | |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Finance |
- Bolsa de valores
- Insiders
- Mark Chin